Experimental Biology and Medicine,
Journal Year:
2024,
Volume and Issue:
249
Published: June 27, 2024
Neurological
pain
(NP)
is
always
accompanied
by
symptoms
of
depression,
which
seriously
affects
physical
and
mental
health.
In
this
study,
we
identified
the
common
hub
genes
(Co-hub
genes)
related
immune
cells
NP
major
depressive
disorder
(MDD)
to
determine
whether
they
have
pathological
molecular
mechanisms.
MDD
expression
data
was
downloaded
from
Gene
Expression
Omnibus
(GEO)
database.
Common
differentially
expressed
(Co-DEGs)
for
were
extracted
nodes
mined.
Co-DEGs,
genes,
analyzed
Ontology
(GO)
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
enrichment.
Finally,
nodes,
obtain
Co-hub
genes.
We
plotted
Receiver
operating
characteristic
(ROC)
curves
evaluate
diagnostic
impact
on
NP.
also
immune-infiltrating
cell
component
ssGSEA
relationship.
For
GO
KEGG
enrichment
analyses,
93
Co-DEGs
associated
with
biological
processes
(BP),
such
as
fibrinolysis,
composition
(CC),
tertiary
granules,
pathways,
complement,
coagulation
cascades.
A
differential
gene
analysis
revealed
significant
differences
between
ANGPT2,
MMP9,
PLAU,
TIMP2.
There
some
accuracy
in
diagnosis
based
ANGPT2
MMP9.
Analysis
components
indicated
an
abundance
activated
dendritic
cells,
effector
memory
CD8
+
T
B
regulatory
both
groups,
statistically
significant.
summary,
6
4
types
MDD.
Further
studies
are
needed
role
these
potential
markers
or
therapeutic
targets
Molecular Medicine Reports,
Journal Year:
2024,
Volume and Issue:
29(3)
Published: Jan. 15, 2024
Capsaicin,
which
is
abundant
in
chili
peppers,
exerts
antioxidative,
antitumor,
antiulcer
and
analgesic
effects
it
has
demonstrated
potential
as
a
treatment
for
cardiovascular,
gastrointestinal,
oncological
dermatological
conditions.
Unique
among
natural
irritants,
capsaicin
initially
excites
neurons
but
then
'calms'
them
into
long‑lasting
non‑responsiveness.
Capsaicin
can
also
promote
weight
loss,
making
potentially
useful
treating
obesity.
Several
mechanisms
have
been
proposed
to
explain
the
therapeutic
of
capsaicin,
including
antioxidation,
analgesia
promotion
apoptosis.
Some
are
be
mediated
by
receptor
(transient
cation
channel
subfamily
V
member
1),
some
independent
that
receptor.
The
clinical
usefulness
limited
its
short
half‑life.
present
review
provided
an
overview
what
known
about
involved
certain
studies
arguing
against
use
were
mentioned.
Healthcare,
Journal Year:
2025,
Volume and Issue:
13(2), P. 127 - 127
Published: Jan. 11, 2025
Background
and
Objectives:
A
degenerative
joint
disease
that
primarily
affects
elderly
individuals,
osteoarthritis
(OA)
causes
pain,
decreased
mobility,
a
lower
quality
of
life.
Procaine
is
regarded
as
“veteran”
medicine
due
to
its
extensive
clinical
use,
although
it
remains
molecule
interest,
researchers
are
uncovering
new
biological
pharmacological
effects
through
innovative
experimental
methods.
This
study
evaluates
the
efficacy
“procaine
complex”,
developed
in
our
country,
alleviating
pain
improving
functionality
individuals
with
knee
hip.
Materials
Methods:
We
conducted
an
assessment
longitudinal
short-term
involving
177
patients
aged
65
older,
who
were
randomly
divided
into
two
groups.
One
group
received
physical
therapy
complex”
periarticular
injections
(n
=
101),
while
other
just
76).
assessed
using
visual
analog
scale
(VAS),
addition
functional
evaluations
Lequesne
Index,
Activities
Daily
Living
(ADL),
Instrumental
ADL
(IADL)
scores.
evaluated
these
CGA
(complex
geriatric
assessment),
walk
test,
“Up
Go”
Mini
Mental
State
(MMSE)
Geriatric
Depression
Scale
(GDS)
for
cognitive
status.
analyzed
all
data
from
this
PSPP
v3
software.
Results:
The
procaine
complex
treatment
exhibited
significant
reduction
(p
<
0.001)
improvement
daily
activities
relative
control
group.
However,
there
was
no
notable
difference
walking
test
scores
0.171).
No
substantial
detrimental
identified.
did
not
surpass
reducing
depressive
disorders,
but
both
groups
showed
some
enhancement
regard.
Conclusions:
demonstrates
approach
management
by
integrating
therapy.
provides
experiencing
limitations
secure
efficacious
alternative
surgery,
or
may
diminish
years
disability.
Frontiers in Molecular Neuroscience,
Journal Year:
2024,
Volume and Issue:
17
Published: Sept. 9, 2024
The
transient
receptor
potential
vanilloid
1
(TRPV1)
channel
plays
a
dual
role
in
peripheral
neuropathic
pain
(NeuP)
by
acting
as
“pain
switch”
through
its
sensitization
and
desensitization.
Hyperalgesia,
commonly
resulting
from
tissue
injury
or
inflammation,
involves
the
of
TRPV1
channels,
which
modulates
sensory
transmission
primary
afferent
nociceptors
to
spinal
dorsal
horn
neurons.
In
chemotherapy-induced
neuropathy
(CIPN),
is
implicated
mechanisms
due
interaction
with
ion
neurotransmitter
signaling,
oxidative
stress.
Sensitization
root
ganglion
neurons
contributes
CIPN
development,
inhibition
channels
can
reduce
mechanical
hypersensitivity.
diabetic
(DPN),
involved
modulation
pathways
including
reactive
oxygen
species
cytokine
production.
TRPV1’s
TRPA1
further
influences
chronic
onset
progression.
Therapeutically,
capsaicin,
agonist,
induce
analgesia
desensitization,
while
antagonists
siRNA
targeting
show
promise
preclinical
studies.
Cannabinoid
provides
another
pathway
for
alleviating
pain.
This
review
summarizes
recent
research
on
association
NeuP.
Pharmaceutics,
Journal Year:
2023,
Volume and Issue:
15(7), P. 1799 - 1799
Published: June 23, 2023
Neuropathic
pain
is
a
debilitating
condition
characterized
by
abnormal
signaling
within
the
nervous
system,
resulting
in
persistent
and
often
intense
sensations
of
pain.
It
can
arise
from
various
causes,
including
traumatic
nerve
injury,
neuropathy,
certain
diseases.
We
present
an
overview
current
emerging
pharmacotherapies
for
neuropathic
pain,
focusing
on
novel
drug
targets
potential
therapeutic
agents.
Current
pharmacotherapies,
tricyclic
antidepressants,
gabapentinoids,
serotonin
norepinephrine
re-uptake
inhibitors,
are
discussed,
as
treatments,
such
ambroxol,
cannabidiol,
N-acetyl-L-cysteine.
Additionally,
article
highlights
need
further
research
this
field
to
identify
new
develop
more
effective
targeted
therapies
management.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(23), P. 16574 - 16574
Published: Nov. 21, 2023
Migraine
is
a
primary
headache
disorder,
which
an
enormous
burden
to
the
healthcare
system.
While
some
aspects
of
pathomechanism
migraines
remain
unknown,
most
accepted
theory
that
activation
and
sensitization
trigeminovascular
system
are
essential
during
migraine
attacks.
In
recent
decades,
it
has
been
suggested
ion
channels
may
be
important
participants
in
pathogenesis
migraine.
Numerous
expressed
peripheral
central
nervous
systems,
including
system,
affecting
neuron
excitability,
synaptic
energy
homeostasis,
inflammatory
signaling,
pain
sensation.
Dysfunction
could
result
neuronal
excitability
or
sensitization.
This
narrative
review
covers
current
understanding
biological
mechanisms
leading
pathway,
with
focus
on
findings
channel
modulation.
Furthermore,
we
kynurenine
pathway
since
this
contains
kynurenic
acid,
endogenous
glutamate
receptor
antagonist
substance,
role
pathophysiology.
Frontiers in Neurology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 10, 2025
Postherpetic
neuralgia
(PHN),
a
representative
type
of
neuropathic
pain,
has
attracted
much
research
on
its
diagnosis
and
therapy
at
the
molecular
level.
Interestingly,
this
study
based
brain-gut
axis
provided
novel
point
view
to
interpret
mechanism
PHN.
Past
neuroanatomical
neuroimaging
studies
pain
suggest
that
prefrontal
cortex,
anterior
cingulate
amygdala,
other
regions
brain
may
play
crucial
roles
in
descending
inhibition
Dominant
bacterial
species
patients
with
PHN,
such
as
Lactobacillus,
generate
short-chain
fatty
acids,
including
butyrate.
Evidence
indicates
disturbance
some
metabolites
(such
butyrate)
is
closely
related
development
hyperalgesia.
In
addition,
tryptophan
5-HT
intestinal
tract
act
neurotransmitters
regulate
transmission
signals.
Concurrently,
enteric
nervous
system
establishes
close
connections
central
through
vagus
nerve
pathways.
This
review
aims
investigate
elucidate
mechanisms
associated
focusing
interplay
among
gut
microbiota,
relevant
while
scrutinizing
pathogenesis.
Cureus,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 1, 2025
Chronic
pain
is
prevalent
and
challenging
to
treat.
Cannabinoids,
in
particular
cannabidiol
(CBD),
have
been
evaluated
as
analgesics
without
the
issues
of
tolerance
or
dependence.
Side
effects
tend
be
mild
infrequent.
These
products
multiple
routes
administration
composition,
some
are
available
over
counter,
allowing
patients
self-medicate.
Most
self-medicated
CBD
plant-derived
extracts
administered
either
oils,
pills,
by
inhalation.
During
early
1960s,
was
chemically
synthesized
for
first
time,
but
it
not
yet
approved
medical
use;
synthetic
has
continues
studied
clinical
trials
numerous
indications,
including
chronic
pain,
neuropathic
cancer.
However,
studies
often
small,
populations
heterogeneous,
results
equivocal.
Research
lively,
with
60
reported
on
ClinicalTrials.gov.
Multimodal
therapy
may
hold
promise,
particularly
combination
palmitoylethanolamide.
Greater
patient
education
training
physicians
other
healthcare
providers
needed
along
more
comprehensive
studies.
Considering
problem
further
intensive
study
control
warranted
meet
this
unmet
need.
This
important
context
long-lasting
methods
that
enable
easy
dosing
support
long-term
use
dealing
persistent
debilitating
symptoms.